Key result
Amiodarone therapy linked to severe SIADH-induced hyponatremia, dropping serum sodium to ~105 mmol/l.
Case Report (n=1)
No
Amiodarone can rarely cause severe, potentially life-threatening SIADH-induced hyponatremia (down to 105 mmol/l), warranting careful monitoring of serum sodium levels during therapy, especially in elderly males.
Answers are grounded in this paper and cite their sources.
May warrant sodium monitoring on amiodarone; leaves open confirmation of incidence and causality.
INTRODUCTION: Hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion (SIADH) during amiodarone therapy is a rare but potentially lethal adverse effect. We report a case of severe hyponatremia associated with amiodarone, and discuss its clinical implications. CASE REPORT: An 84-year-old Caucasian man with a past medical history of hypertension and diabetes was admitted to the hospital with a non-ST elevation myocardial infarction. He underwent coronary artery bypass graft and developed atrial fibrillation on postoperative day 2. A loading dose of amiodarone followed by a maintenance dose was started. The serum sodium level was 136 mmol/l at discharge and subsequently decreased to 105 mmol/l 11 days later, at which time the patient represented with altered mental status. The diagnosis of SIADH was made based on euvolemic hypoosmotic hyponatremia, lack of any other medication known to cause SIADH and urine that was less than maximally dilute. The serum sodium increased gradually to 123 mmol/l after 36 h of treatment with hypertonic saline, demeclocycline and fluid restriction. CONCLUSION: SIADH-induced hyponatremia associated with amiodarone occurs rarely. Since severe hyponatremia is associated with significant neurological damage and mortality, clinicians should carefully monitor serum sodium during amiodarone therapy.
No takes yet. Share an insight, caveat, or question.
Pham et al. (2013) conducted a case report in Postoperative atrial fibrillation complicated by amiodarone-induced SIADH and severe hyponatremia (n=1). Amiodarone was evaluated on Serum sodium level (SIADH-induced hyponatremia). Amiodarone therapy was associated with severe SIADH-induced hyponatremia, reducing serum sodium from 136 mmol/l at discharge to 105 mmol/l 11 days later.
Synapse has enriched 10 related papers. Consider them for comparative context: